** Shares of the drug maker Viatris VTRS.O rise about 2.6% to $7.82 premarket
** Co says would pay up to $335 mln over nine years as part of a nationwide settlement to resolve opioid related claims
** VTRS to pay between $27.5 mln to $40 mln annually toward state and local opioid initiatives
** As of last close, stock down 38.8% YTD
(Reporting by Sruthi Narasimha Chari in Bengaluru)
((Sruthinarasimha.chari@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.